DeNovaMed Competitors and Similar CompaniesClear all
DeNovaMed's competitors and similar companies include Kangstem Biotech, Corestem, Triumvira and Sanofi.
 DeNovaMed DeNovaMed is a pharmaceutical company specializing in therapeutic approaches to combat bacterial infections. |  Kangstem Biotech Kangstem Biotech (강스템바이오텍) is a biopharmaceutical company that focuses on blood-derived stem cell therapy. |  Corestem Corestem (코아스템) is a biopharmaceutical company that researches and commercializes stem cell technology. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | ||
Founding Date | Founding Date 2006 | Founding Date 2010 | Founding Date 2003 | Founding Date 2015 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Halifax, CA HQ Toronto, CA | Locations KR HQ | Locations Seongnam-si, KR HQ | Locations Austin, US HQ Hamilton, CA | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 6 | Employees 97 | Employees 354 | Employees 287% decrease | Employees 82,878 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₩7.7b (FY, 2024) | Revenue (est.) ₩28.8b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₩838.6m (FY, 2024) | Cost of goods ₩25.6b (FY, 2024) | Cost of goods N/A | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₩7.1b (FY, 2024) | Gross profit ₩5.6b (FY, 2024) | Gross profit N/A | Gross profit €37.6b (FY, 2025) |
Net income | Net income N/A | Net income (₩7.1b) (FY, 2024) | Net income (₩26.3b) (FY, 2024) | Net income N/A | Net income €8b (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 500k (about 14 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 55m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Kangstem Biotech
HQ
KR
Employees
97
Kangstem Biotech (강스템바이오텍) is a biopharmaceutical company that focuses on blood-derived stem cell therapy.
View companyCorestem
HQ
Seongnam-si, KR
Employees
354
Corestem (코아스템) is a biopharmaceutical company that researches and commercializes stem cell technology.
View company
Triumvira
HQ
Austin, US
Employees
28↓ 7% decrease
Triumvira Immunologics is an immunotherapy company.
View companySanofi
HQ
Paris, FR
Employees
82,878
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company